Cancer research using experimental models—everything from cancer cells in a dish to patient tumors transplanted in mice—has been extremely useful for learning more about the disease and how we might treat it. For some ...
Feb 10, 2020
0
140
A recent study led by Boston University School of Medicine (BUSM) demonstrates that the A2b-type adenosine receptor, A2bAR, plays a significant role in the regulation of high fat, high cholesterol diet-induced symptoms of ...
Jul 26, 2012
0
0
A City of Hope scientist is one step closer to discovering what weakens a pathogen that appears to cause babies to be born with abnormally small heads.
Mar 30, 2020
0
0
Although today's rheumatoid arthritis treatments can reduce symptoms, they often come with serious side effects. Results from a new mouse study suggest that a new light-activated drug delivery method helps confine treatments ...
Apr 27, 2020
0
2
Researchers have developed a computational model for human MEK1, a protein with potential as a drug target for a variety of human cancers.
Apr 3, 2019
0
6
Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them. The ...
Apr 22, 2013
1
0
(Medical Xpress) -- Mark Davis, PhD, director of Stanford’s Institute for Immunity, Transplantation and Infection, has used mice to brilliant effect. They have helped him and a legion of fellow immunologists unravel many ...
Jan 23, 2012
0
0
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...
Jan 17, 2018
0
9
Even the humble fruit fly craves a dose of the happy hormone, according to a new study from the University of Sussex which shows how they may use dopamine to learn in a similar manner to humans.
May 7, 2021
0
80
Dr Changfa Guo, Professor Chunsheng Wang and their co-investigators from Zhongshan hospital Fudan University, Shanghai, China have established a novel hyperbranched poly(amidoamine) (hPAMAM) nanoparticle based hypoxia regulated ...
Jul 6, 2012
0
0
